SPEN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.280200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.875600E-01
Normal-vs-Stage2
3.627600E-01
Normal-vs-Stage3
1.952830E-01
Normal-vs-Stage4
5.584800E-01
Stage1-vs-Stage2
8.603600E-01
Stage1-vs-Stage3
1.049730E-02
Stage1-vs-Stage4
8.873600E-02
Stage2-vs-Stage3
4.519500E-02
Stage2-vs-Stage4
2.771600E-02
Stage3-vs-Stage4
1.091760E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.865600E-01
Normal-vs-AfricanAmerican
8.657200E-01
Normal-vs-Asian
4.771600E-01
Caucasian-vs-AfricanAmerican
2.707800E-01
Caucasian-vs-Asian
8.394400E-01
AfricanAmerican-vs-Asian
4.576400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.471800E-01
Normal-vs-Female
3.306800E-01
Male-vs-Female
9.862000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.798800E-01
Normal-vs-Age(41-60Yrs)
7.274200E-01
Normal-vs-Age(61-80Yrs)
2.227600E-01
Normal-vs-Age(81-100Yrs)
5.683900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.993600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.709000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.823900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.457800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.456600E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.206030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.604800E-01
Normal-vs-Daily Drinker
3.040000E-01
Normal-vs-Weekly Drinker
2.155000E-01
Normal-vs-Occasional Drinker
7.382200E-01
Normal-vs-Social Drinker
4.138400E-01
Non Drinker-vs-Daily Drinker
5.395200E-01
Non Drinker-vs-Weekly Drinker
6.719600E-01
Non Drinker-vs-Occasional Drinker
4.826100E-02
Non Drinker-vs-Social Drinker
2.199800E-01
Daily Drinker-vs-Weekly Drinker
8.876000E-01
Daily Drinker-vs-Occasional Drinker
1.961030E-01
Daily Drinker-vs-Social Drinker
5.541000E-01
Weekly Drinker-vs-Occasional Drinker
1.723410E-01
Weekly Drinker-vs-Social Drinker
4.459800E-01
Occasional Drinker-vs-Social Drinker
4.765400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.852200E-01
Normal-vs-Grade 2
7.307600E-02
Normal-vs-Grade 3
2.928000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.558440E-01
Grade 1-vs-Grade 3
2.275600E-01
Grade 1-vs-Grade 4
2.852200E-01
Grade 2-vs-Grade 3
9.551200E-01
Grade 2-vs-Grade 4
7.307600E-02
Grade 3-vs-Grade 4
2.928000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.041400E-01
Normal-vs-NonDiabetic
2.769200E-01
Diabetic-vs-NonDiabetic
5.644400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.242200E-01
Normal-vs-NoPancreatitis
2.891800E-01
Pancreatitis-vs-NoPancreatitis
8.712800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.107000E-01
Normal-vs-N1
3.746600E-01
N0-vs-N1
1.773200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.694600E-01
Normal-vs-TP53-NonMutant
4.549200E-01
TP53-Mutant-vs-TP53-NonMutant
2.215000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
